So now the basher spin seems to be: it's bad to do well in Phase 1 and Phase 2 because then you'll have to spend money for Phase 3 trials.

Well, I guess that means NNVC is the perfect investment for them, because they're STILL nowhere near human trials.

Geeze these guys are really reaching now.